Vault-13

SPHERA FUNDS MANAGEMENT LTD.

TEL AVIV, L3 · CIK 1496201 · 13F filing filed 2025-08-14

Exempt reporting adviser since 2021 · other (specify)

As an employer

$382.5m reported value -5.7% vs Q1 2025
101positions
34.8%in top 10
16 new 23 added 53 reduced 27 sold out vs Q1 2025

Options: 7 call positions ($24.9m notional), 2 put positions ($18.7m notional) – listed below, not included above.

This report includes the holdings of 2 other managers that share the investment decisions:

Shares in two reports are counted once in each security's totals.

Holdings, Q2 2025

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS SPONSORED ADS 1,620,990 $27.2m7.10% 7.10% AddedShares held: Q3 2024 2.1m, Q4 2024 1.6m, Q1 2025 1.6m, Q2 2025 1.6m +48.8k +48,809 3.1%
2 NOVA LTD COM NVMI NVMI 75,836 $20.9m5.46% 5.46% ReducedShares held: Q3 2024 52.0k, Q4 2024 68.1k, Q1 2025 90.7k, Q2 2025 75.8k -14.9k -14,861 -16.4%
3 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 1,571,564 $14.7m3.85% 3.85% ReducedShares held: Q3 2024 1.0m, Q4 2024 1.4m, Q1 2025 1.7m, Q2 2025 1.6m -92.4k -92,410 -5.5%
4 TOWER SEMICONDUCTOR LTD SHS NEW TSEM TSEM 264,722 $11.5m3.00% 3.00% AddedShares held: Q3 2024 209.4k, Q4 2024 166.1k, Q1 2025 61.5k, Q2 2025 264.7k +203.2k +203,173 330.1%
5 CYTOKINETICS INC COM NEW CYTK CYTK 326,718 $10.8m2.82% 2.82% AddedShares held: Q3 2024 225.0k, Q4 2024 153.0k, Q1 2025 145.0k, Q2 2025 326.7k +181.8k +181,757 125.4%
6 SANOFI SPONSORED ADR SNY SNY 219,515 $10.6m2.77% 2.77% ReducedShares held: Q3 2024 409.5k, Q4 2024 384.5k, Q1 2025 304.5k, Q2 2025 219.5k -85.0k -85,000 -27.9%
7 BIOGEN INC COM BIIB BIIB 82,738 $10.4m2.72% 2.72% AddedShares held: Q3 2024 24.5k, Q4 2024 22.7k, Q1 2025 22.7k, Q2 2025 82.7k +60.0k +60,000 263.9%
8 ASTRAZENECA PLC SPONSORED ADR SPONSORED ADR 135,060 $9.4m2.47% 2.47% ReducedShares held: Q3 2024 190.1k, Q4 2024 225.1k, Q1 2025 175.1k, Q2 2025 135.1k -40.0k -40,000 -22.9%
9 ELI LILLY & CO COM LLY LLY 11,540 $9.0m2.35% 2.35% ReducedShares held: Q3 2024 13.2k, Q4 2024 13.2k, Q1 2025 11.7k, Q2 2025 11.5k -150 -150 -1.3%
10 NVIDIA CORPORATION COM NVDA NVDA 54,515 $8.6m2.25% 2.25% AddedShares held: Q3 2024 24.4k, Q4 2024 0, Q1 2025 29.6k, Q2 2025 54.5k +24.9k +24,910 84.1%
11 CELLDEX THERAPEUTICS INC NEW COM NEW CLDX CLDX 419,540 $8.5m2.23% 2.23% ReducedShares held: Q3 2024 419.1k, Q4 2024 474.1k, Q1 2025 507.8k, Q2 2025 419.5k -88.3k -88,289 -17.4%
12 NOVO-NORDISK A S ADR NVO NVO 105,677 $7.3m1.91% 1.91% ReducedShares held: Q3 2024 78.1k, Q4 2024 98.1k, Q1 2025 118.1k, Q2 2025 105.7k -12.4k -12,403 -10.5%
13 AMAZON COM INC COM AMZN AMZN 32,441 $7.1m1.86% 1.86% ReducedShares held: Q3 2024 105.6k, Q4 2024 62.6k, Q1 2025 36.6k, Q2 2025 32.4k -4.2k -4,166 -11.4%
14 CIDARA THERAPEUTICS INC COM NEW CDTX CDTX 138,001 $6.7m1.76% 1.76% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 17.1k, Q2 2025 138.0k +120.9k +120,873 705.7%
15 ORMAT TECHNOLOGIES INC COM ORA ORA 78,000 $6.5m1.71% 1.71% ReducedShares held: Q3 2024 0, Q4 2024 79.0k, Q1 2025 84.0k, Q2 2025 78.0k -6.0k -6,000 -7.1%
16 MINERALYS THERAPEUTICS INC COM MLYS MLYS 480,974 $6.5m1.70% 1.70% AddedShares held: Q3 2024 272.5k, Q4 2024 190.7k, Q1 2025 465.5k, Q2 2025 481.0k +15.4k +15,448 3.3%
17 FORTE BIOSCIENCES INC COM NEW FBRX FBRX 495,109 $6.4m1.67% 1.67% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 495.1k
18 META PLATFORMS INC CL A META META 8,526 $6.3m1.65% 1.65% ReducedShares held: Q3 2024 29.3k, Q4 2024 21.0k, Q1 2025 10.0k, Q2 2025 8.5k -1.4k -1,436 -14.4%
19 JOHNSON & JOHNSON COM JNJ JNJ 40,831 $6.2m1.63% 1.63% ReducedShares held: Q3 2024 69.8k, Q4 2024 69.8k, Q1 2025 52.8k, Q2 2025 40.8k -12.0k -12,000 -22.7%
20 MICROSOFT CORP COM MSFT MSFT 11,792 $5.9m1.53% 1.53% AddedShares held: Q3 2024 33.4k, Q4 2024 22.3k, Q1 2025 4.6k, Q2 2025 11.8k +7.2k +7,200 156.8%
21 AMICUS THERAPEUTICS INC COM FOLD FOLD 990,718 $5.7m1.48% 1.48% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 990.7k
22 ORMAT TECHNOLOGIES INC DEBT 2.500% 7/1 ORA 2.5 07.15.27 SEPT ORA 2.5 07.15.27 SEPT 5,037,000 $5.6m1.47% 1.47% UnchangedShares held: Q3 2024 5.0m, Q4 2024 5.0m, Q1 2025 5.0m, Q2 2025 5.0m
23 PHARVARIS N V COM PHVS PHVS 309,931 $5.5m1.43% 1.43% ReducedShares held: Q3 2024 439.3k, Q4 2024 388.2k, Q1 2025 383.9k, Q2 2025 309.9k -73.9k -73,925 -19.3%
24 ELEDON PHARMACEUTICALS INC COM ELDN ELDN 1,959,610 $5.3m1.39% 1.39% ReducedShares held: Q3 2024 1.3m, Q4 2024 2.6m, Q1 2025 2.3m, Q2 2025 2.0m -347.5k -347,509 -15.1%
25 TRAVERE THERAPEUTICS INC COM TVTX TVTX 335,333 $5.0m1.30% 1.30% AddedShares held: Q3 2024 0, Q4 2024 220.7k, Q1 2025 200.0k, Q2 2025 335.3k +135.3k +135,333 67.7%
26 ABBVIE INC COM ABBV ABBV 25,256 $4.7m1.23% 1.23% ReducedShares held: Q3 2024 38.0k, Q4 2024 34.3k, Q1 2025 30.3k, Q2 2025 25.3k -5.0k -5,000 -16.5%
27 GSK PLC SPONSORED ADR GSK GSK 122,000 $4.7m1.22% 1.22% ReducedShares held: Q3 2024 100.0k, Q4 2024 130.0k, Q1 2025 130.0k, Q2 2025 122.0k -8.0k -8,000 -6.2%
28 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 109,757 $4.6m1.21% 1.21% ReducedShares held: Q3 2024 152.3k, Q4 2024 91.6k, Q1 2025 140.7k, Q2 2025 109.8k -30.9k -30,903 -22.0%
29 NOVARTIS AG SPONSORED ADR NVS NVS 37,000 $4.5m1.17% 1.17% ReducedShares held: Q3 2024 50.0k, Q4 2024 50.0k, Q1 2025 50.0k, Q2 2025 37.0k -13.0k -13,000 -26.0%
30 TREVI THERAPEUTICS INC COM TRVI TRVI 799,957 $4.4m1.14% 1.14% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 800.0k
31 MAZE THERAPEUTICS INC COM MAZE MAZE 356,453 $4.4m1.14% 1.14% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 355.6k, Q2 2025 356.5k +899 +899 0.2%
32 ANNEXON INC COM ANNX ANNX 1,764,387 $4.2m1.11% 1.11% UnchangedShares held: Q3 2024 0, Q4 2024 1.2m, Q1 2025 1.8m, Q2 2025 1.8m
33 IMMUNOVANT INC COM IMVT IMVT 256,743 $4.1m1.07% 1.07% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 194.6k, Q2 2025 256.7k +62.1k +62,105 31.9%
34 ORIC PHARMACEUTICALS INC COM ORIC ORIC 394,693 $4.0m1.05% 1.05% AddedShares held: Q3 2024 128.4k, Q4 2024 273.2k, Q1 2025 234.8k, Q2 2025 394.7k +159.9k +159,859 68.1%
35 MERCK & CO INC COM MRK MRK 48,600 $3.8m1.01% 1.01% ReducedShares held: Q3 2024 59.6k, Q4 2024 59.6k, Q1 2025 59.6k, Q2 2025 48.6k -11.0k -11,000 -18.5%
36 ACADIA PHARMACEUTICALS INC COM ACAD ACAD 174,900 $3.8m0.99% 0.99% NewShares held: Q3 2024 252.5k, Q4 2024 288.5k, Q1 2025 0, Q2 2025 174.9k
37 BRIDGEBIO PHARMA INC COM BBIO BBIO 87,108 $3.8m0.98% 0.98% ReducedShares held: Q3 2024 842.6k, Q4 2024 905.3k, Q1 2025 366.6k, Q2 2025 87.1k -279.5k -279,500 -76.2%
38 ULTRAGENYX PHARMACEUTICAL IN COM RARE RARE 100,085 $3.6m0.95% 0.95% ReducedShares held: Q3 2024 195.3k, Q4 2024 228.8k, Q1 2025 267.4k, Q2 2025 100.1k -167.3k -167,300 -62.6%
39 AVIDITY BIOSCIENCES INC COM RNA RNA 126,000 $3.6m0.94% 0.94% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 106.0k, Q2 2025 126.0k +20.0k +20,000 18.9%
40 ALPHA COGNITION INC COM NEW ACOG ACOG 376,649 $3.5m0.92% 0.92% ReducedShares held: Q3 2024 0, Q4 2024 620.0k, Q1 2025 597.0k, Q2 2025 376.6k -220.3k -220,343 -36.9%
41 REZOLUTE INC COM NEW RZLT RZLT 751,447 $3.4m0.88% 0.88% ReducedShares held: Q3 2024 1.2m, Q4 2024 1.2m, Q1 2025 1.1m, Q2 2025 751.4k -330.0k -330,000 -30.5%
42 CYBIN INC COM NEW COM NEW 398,309 $3.3m0.87% 0.87% ReducedShares held: Q3 2024 933.2k, Q4 2024 538.1k, Q1 2025 527.2k, Q2 2025 398.3k -128.9k -128,913 -24.4%
43 APPLIED MATLS INC COM AMAT AMAT 18,000 $3.3m0.86% 0.86% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 18.0k, Q2 2025 18.0k
44 ARROWHEAD PHARMACEUTICALS IN COM ARWR ARWR 202,996 $3.2m0.84% 0.84% ReducedShares held: Q3 2024 0, Q4 2024 197.6k, Q1 2025 277.6k, Q2 2025 203.0k -74.6k -74,554 -26.9%
45 IMMATICS N.V SHS IMTX IMTX 583,105 $3.1m0.82% 0.82% ReducedShares held: Q3 2024 721.1k, Q4 2024 921.1k, Q1 2025 921.1k, Q2 2025 583.1k -338.0k -338,006 -36.7%
46 SAVARA INC COM SVRA SVRA 1,310,233 $3.0m0.78% 0.78% AddedShares held: Q3 2024 563.1k, Q4 2024 1.2m, Q1 2025 1.3m, Q2 2025 1.3m +26.1k +26,082 2.0%
47 UBER TECHNOLOGIES INC COM UBER UBER 30,000 $2.8m0.73% 0.73% UnchangedShares held: Q3 2024 0, Q4 2024 30.0k, Q1 2025 30.0k, Q2 2025 30.0k
48 SAREPTA THERAPEUTICS INC COM SRPT SRPT 159,323 $2.7m0.71% 0.71% AddedShares held: Q3 2024 125.8k, Q4 2024 98.9k, Q1 2025 157.9k, Q2 2025 159.3k +1.4k +1,392 0.9%
49 CAMTEK LTD ORD CAMT CAMT 31,976 $2.7m0.71% 0.71% AddedShares held: Q3 2024 36.3k, Q4 2024 36.3k, Q1 2025 23.1k, Q2 2025 32.0k +8.9k +8,890 38.5%
50 ELBIT SYS LTD ORD ESLT ESLT 6,000 $2.7m0.71% 0.71% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 6.0k
51 PALO ALTO NETWORKS INC COM PANW PANW 13,114 $2.7m0.70% 0.70% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 13.1k
52 WIX COM LTD SHS WIX WIX 16,931 $2.7m0.70% 0.70% AddedShares held: Q3 2024 34.3k, Q4 2024 39.3k, Q1 2025 8.8k, Q2 2025 16.9k +8.1k +8,131 92.4%
53 AMGEN INC COM AMGN AMGN 9,500 $2.7m0.69% 0.69% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 10.0k, Q2 2025 9.5k -500 -500 -5.0%
54 SOLAREDGE TECHNOLOGIES INC COM SEDG SEDG 127,966 $2.6m0.68% 0.68% ReducedShares held: Q3 2024 0, Q4 2024 375.0k, Q1 2025 309.2k, Q2 2025 128.0k -181.2k -181,250 -58.6%
55 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 128,515 $2.6m0.67% 0.67% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 111.7k, Q2 2025 128.5k +16.8k +16,772 15.0%
56 SKYE BIOSCIENCE INC COM NEW COM NEW 538,434 $2.3m0.59% 0.59% ReducedShares held: Q3 2024 1.6m, Q4 2024 1.6m, Q1 2025 1.5m, Q2 2025 538.4k -937.9k -937,919 -63.5%
57 DYNE THERAPEUTICS INC COM DYN DYN 221,416 $2.1m0.55% 0.55% ReducedShares held: Q3 2024 56.5k, Q4 2024 236.3k, Q1 2025 329.3k, Q2 2025 221.4k -107.8k -107,846 -32.8%
58 PFIZER INC COM PFE PFE 86,000 $2.1m0.55% 0.55% ReducedShares held: Q3 2024 90.0k, Q4 2024 90.0k, Q1 2025 90.0k, Q2 2025 86.0k -4.0k -4,000 -4.4%
59 BIOHAVEN LTD COM BHVN BHVN 145,372 $2.1m0.54% 0.54% AddedShares held: Q3 2024 133.3k, Q4 2024 156.5k, Q1 2025 99.8k, Q2 2025 145.4k +45.6k +45,588 45.7%
60 SCHOLAR ROCK HLDG CORP COM SRRK SRRK 57,497 $2.0m0.53% 0.53% ReducedShares held: Q3 2024 166.9k, Q4 2024 90.2k, Q1 2025 78.2k, Q2 2025 57.5k -20.7k -20,696 -26.5%
61 89BIO INC COM ETNB ETNB 205,675 $2.0m0.53% 0.53% ReducedShares held: Q3 2024 536.5k, Q4 2024 556.5k, Q1 2025 618.3k, Q2 2025 205.7k -412.7k -412,668 -66.7%
62 STRUCTURE THERAPEUTICS INC SPONSORED ADS GPCR GPCR 95,931 $2.0m0.52% 0.52% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 84.0k, Q2 2025 95.9k +11.9k +11,931 14.2%
63 JANUX THERAPEUTICS INC COM JANX JANX 85,840 $2.0m0.52% 0.52% ReducedShares held: Q3 2024 0, Q4 2024 68.3k, Q1 2025 125.8k, Q2 2025 85.8k -40.0k -40,000 -31.8%
64 APELLIS PHARMACEUTICALS INC COM APLS APLS 114,346 $2.0m0.52% 0.52% ReducedShares held: Q3 2024 215.9k, Q4 2024 206.3k, Q1 2025 181.3k, Q2 2025 114.3k -67.0k -67,000 -37.0%
65 SALESFORCE INC COM CRM CRM 6,800 $1.9m0.48% 0.48% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 9.1k, Q2 2025 6.8k -2.3k -2,300 -25.3%
66 ENGENE HOLDINGS INC COM COM 504,409 $1.8m0.48% 0.48% ReducedShares held: Q3 2024 0, Q4 2024 560.0k, Q1 2025 528.4k, Q2 2025 504.4k -24.0k -23,956 -4.5%
67 CYBERARK SOFTWARE LTD SHS CYBR CYBR 4,000 $1.6m0.43% 0.43% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 4.0k
68 MARVELL TECHNOLOGY INC COM MRVL MRVL 18,730 $1.4m0.38% 0.38% AddedShares held: Q3 2024 87.6k, Q4 2024 78.6k, Q1 2025 15.1k, Q2 2025 18.7k +3.7k +3,660 24.3%
69 ASTRIA THERAPEUTICS INC COM CATB CATB 257,402 $1.4m0.36% 0.36% AddedShares held: Q3 2024 136.6k, Q4 2024 139.8k, Q1 2025 189.8k, Q2 2025 257.4k +67.6k +67,602 35.6%
70 KURA ONCOLOGY INC COM KURA KURA 235,522 $1.4m0.36% 0.36% ReducedShares held: Q3 2024 610.1k, Q4 2024 610.1k, Q1 2025 343.5k, Q2 2025 235.5k -108.0k -108,000 -31.4%
71 ISHARES BITCOIN TRUST ETF SHS BEN INT IBIT IBIT 21,455 $1.3m0.34% 0.34% AddedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 8.2k, Q2 2025 21.5k +13.3k +13,305 163.2%
72 INTELLIA THERAPEUTICS INC COM NTLA NTLA 128,780 $1.2m0.32% 0.32% ReducedShares held: Q3 2024 291.1k, Q4 2024 466.1k, Q1 2025 381.1k, Q2 2025 128.8k -252.3k -252,300 -66.2%
73 VENTYX BIOSCIENCES INC COM VTYX VTYX 555,814 $1.2m0.31% 0.31% ReducedShares held: Q3 2024 1.0m, Q4 2024 1.0m, Q1 2025 1.0m, Q2 2025 555.8k -456.9k -456,935 -45.1%
74 ADVANCED MICRO DEVICES INC COM AMD AMD 8,250 $1.2m0.31% 0.31% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 8.2k
75 NANO DIMENSION LTD SPONSORD ADS NEW NNDM NNDM 717,518 $1.2m0.30% 0.30% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 717.5k, Q2 2025 717.5k
76 DAY ONE BIOPHARMACEUTICALS I COM COM 175,371 $1.1m0.30% 0.30% ReducedShares held: Q3 2024 347.6k, Q4 2024 335.0k, Q1 2025 335.0k, Q2 2025 175.4k -159.6k -159,616 -47.6%
77 CEVA INC COM CEVA CEVA 48,920 $1.1m0.28% 0.28% UnchangedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 48.9k, Q2 2025 48.9k
78 PERSPECTIVE THERAPEUTICS INC COM NEW CATX CATX 310,343 $1.1m0.28% 0.28% ReducedShares held: Q3 2024 589.3k, Q4 2024 460.2k, Q1 2025 460.2k, Q2 2025 310.3k -149.9k -149,904 -32.6%
79 COGENT BIOSCIENCES INC COM COGT COGT 143,693 $1.0m0.27% 0.27% ReducedShares held: Q3 2024 0, Q4 2024 0, Q1 2025 335.0k, Q2 2025 143.7k -191.3k -191,331 -57.1%
80 KRYSTAL BIOTECH INC COM KRYS KRYS 7,335 $1.0m0.26% 0.26% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 7.3k
81 TAYSHA GENE THERAPIES INC COM SHS TSHA TSHA 420,000 $970.2k0.25% 0.25% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 420.0k
82 PROMIS NEUROSCIENCES INC COM NEW PMN PMN 1,899,297 $918.9k0.24% 0.24% ReducedShares held: Q3 2024 1.9m, Q4 2024 1.9m, Q1 2025 1.9m, Q2 2025 1.9m -30.0k -30,000 -1.6%
83 VISTAGEN THERAPEUTICS INC COM VTGN VTGN 447,939 $895.9k0.23% 0.23% ReducedShares held: Q3 2024 808.5k, Q4 2024 808.5k, Q1 2025 790.5k, Q2 2025 447.9k -342.6k -342,611 -43.3%
84 CHEMOMAB THERAPEUTICS LTD SPONSORED ADS SPONSORED ADS 738,048 $856.1k0.22% 0.22% ReducedShares held: Q3 2024 1.2m, Q4 2024 1.2m, Q1 2025 900.4k, Q2 2025 738.0k -162.4k -162,380 -18.0%
85 BRISTOL-MYERS SQUIBB CO COM BMY BMY 17,500 $810.1k0.21% 0.21% ReducedShares held: Q3 2024 0, Q4 2024 20.0k, Q1 2025 20.0k, Q2 2025 17.5k -2.5k -2,500 -12.5%
86 CORVUS PHARMACEUTICALS INC COM CRVS CRVS 183,094 $732.4k0.19% 0.19% ReducedShares held: Q3 2024 0, Q4 2024 500.5k, Q1 2025 205.9k, Q2 2025 183.1k -22.8k -22,765 -11.1%
87 WEREWOLF THERAPEUTICS INC COM HOWL HOWL 626,810 $683.2k0.18% 0.18% UnchangedShares held: Q3 2024 626.8k, Q4 2024 626.8k, Q1 2025 626.8k, Q2 2025 626.8k
88 VERASTEM INC COM NEW VSTM VSTM 163,307 $677.7k0.18% 0.18% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 163.3k
89 BICARA THERAPEUTICS INC COM BCAX BCAX 65,679 $610.2k0.16% 0.16% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 65.7k
90 LARIMAR THERAPEUTICS INC COM LRMR LRMR 196,635 $568.3k0.15% 0.15% ReducedShares held: Q3 2024 414.5k, Q4 2024 455.6k, Q1 2025 366.3k, Q2 2025 196.6k -169.7k -169,669 -46.3%
91 SENTINELONE INC CL A S S 27,000 $493.6k0.13% 0.13% NewShares held: Q3 2024 276.6k, Q4 2024 0, Q1 2025 0, Q2 2025 27.0k
92 APREA THERAPEUTICS INC COM NEW APRE APRE 270,000 $456.3k0.12% 0.12% UnchangedShares held: Q3 2024 270.0k, Q4 2024 270.0k, Q1 2025 270.0k, Q2 2025 270.0k
93 COGNYTE SOFTWARE LTD ORD SHS CGNT CGNT 45,181 $417.5k0.11% 0.11% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 45.2k
94 KEZAR LIFE SCIENCES INC COM NEW KZR KZR 58,539 $268.1k0.07% 0.07% ReducedShares held: Q3 2024 0, Q4 2024 108.5k, Q1 2025 108.5k, Q2 2025 58.5k -49.9k -49,934 -46.0%
95 CLIMB BIO INC COM CLYM CLYM 209,837 $260.2k0.07% 0.07% ReducedShares held: Q3 2024 182.0k, Q4 2024 251.9k, Q1 2025 241.9k, Q2 2025 209.8k -32.1k -32,098 -13.3%
96 SOLID BIOSCIENCES INC COM NEW SLDB SLDB 50,190 $244.4k0.06% 0.06% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 50.2k
97 PEPGEN INC COM PEPG PEPG 156,467 $173.7k0.05% 0.05% NewShares held: Q3 2024 0, Q4 2024 0, Q1 2025 0, Q2 2025 156.5k
98 ONKURE THERAPEUTICS INC COM CL A OKUR OKUR 60,454 $144.5k0.04% 0.04% ReducedShares held: Q3 2024 0, Q4 2024 87.4k, Q1 2025 80.5k, Q2 2025 60.5k -20.0k -20,000 -24.9%
99 ELEVATION ONCOLOGY INC COM COM 328,562 $120.6k0.03% 0.03% ReducedShares held: Q3 2024 1.1m, Q4 2024 1.0m, Q1 2025 358.6k, Q2 2025 328.6k -30.0k -30,000 -8.4%
100 JASPER THERAPEUTICS INC COM NEW JSPR JSPR 14,671 $81.4k0.02% 0.02% ReducedShares held: Q3 2024 189.3k, Q4 2024 135.7k, Q1 2025 122.0k, Q2 2025 14.7k -107.3k -107,346 -88.0%

Sold out since Q1 2025

SecurityTickerShares held beforeValue then
NICE LTD NICE NICE 33,303 $5.1m33.3k shares
MERUS N V MRUS MRUS 106,532 $4.5m106.5k shares
VIGIL NEUROSCIENCE INC VIGL VIGL 1,604,429 $2.9m1.6m shares
WORKDAY INC WDAY WDAY 10,000 $2.3m10.0k shares
SPRINGWORKS THERAPEUTICS INC SWTX SWTX 52,009 $2.3m52.0k shares
ALPHABET INC GOOG GOOG 13,500 $2.1m13.5k shares
VIKING THERAPEUTICS INC VKTX VKTX 83,270 $2.0m83.3k shares
BROADCOM INC AVGO AVGO 11,695 $2.0m11.7k shares
IONIS PHARMACEUTICALS INC IONS IONS 63,821 $1.9m63.8k shares
NIKE INC NKE NKE 30,050 $1.9m30.1k shares
CHECK POINT SOFTWARE TECH LT CHKP CHKP 8,334 $1.9m8.3k shares
ROCKET PHARMACEUTICALS INC RCKT RCKT 271,792 $1.8m271.8k shares
NUTRIEN LTD NTR NTR 30,894 $1.5m30.9k shares
JFROG LTD FROG FROG 42,871 $1.4m42.9k shares
SHL TELEMEDICINE LTD SHLT SHLT 632,456 $1.3m632.5k shares
INOZYME PHARMA INC 1,191,140 $1.1m1.2m shares
OUTLOOK THERAPEUTICS INC OTLK OTLK 857,142 $1.0m857.1k shares
ARVINAS INC ARVN ARVN 125,000 $877.5k125.0k shares
XENON PHARMACEUTICALS INC XENE XENE 26,097 $875.6k26.1k shares
PERION NETWORK LTD PERI PERI 102,612 $835.3k102.6k shares
REGULUS THERAPEUTICS INC RGLS RGLS 452,845 $792.5k452.8k shares
VIR BIOTECHNOLOGY INC VIR VIR 90,855 $588.7k90.9k shares
ZURA BIO LTD ZURA ZURA 421,229 $543.4k421.2k shares
FATE THERAPEUTICS INC FATE FATE 397,177 $313.8k397.2k shares
ALECTOR INC ALEC ALEC 109,208 $134.3k109.2k shares

Options (notional value)

UnderlyingTickerTypeShares controlled NotionalChange
SPDR SER TR XBI · Put XBIPut 200,000 $16.6m200.0k shares New
ULTRAGENYX PHARMACEUTICAL IN RARE · Call RARECall 180,600 $6.6m180.6k shares Added
MOONLAKE IMMUNOTHERAPEUTICS MLTX · Call MLTXCall 125,000 $5.9m125.0k shares New
PRAXIS PRECISION MEDICINES I PRAX · Call PRAXCall 100,000 $4.2m100.0k shares Unchanged
ISHARES TR TLT · Call TLTCall 47,000 $4.1m47.0k shares Reduced
SAREPTA THERAPEUTICS INC SRPT · Call SRPTCall 150,000 $2.6m150.0k shares New
BRIDGEBIO PHARMA INC BBIO · Put BBIOPut 49,900 $2.2m49.9k shares New
COGENT BIOSCIENCES INC COGT · Call COGTCall 200,000 $1.4m200.0k shares New
ELEDON PHARMACEUTICALS INC ELDN · Call ELDNCall 31,200 $84.6k31.2k shares New

Stakes above 5%

Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.

CompanyTickerStakeChange ScheduleLast filed
PROMIS NEUROSCIENCES INC PMN · 13G · filed 2026-02-05 PMN 7.8% +2.3 pts 13G 2026-02-05
TENAX THERAPEUTICS INC TENX · 13G · filed 2026-10-13 TENX 7.1%≈ $38.8m +1.8 pts 13G 2026-10-13